ACHE and Alzheimer disease: Inhibition of acetylcholinesterase (AChE), which breaks down ACh, is considered a primary therapeutic option for AD and helps to maintain the lifespan of neurotransmitters in the cerebral cortex (Phyu et al. 2014).